Using a Patient-Centered Risk-Benefit Structure and Appropriate Manufacturing Practices (AMPs) for Successfully Developing and Manufacturing Effective Cell Therapy Products
{"title":"Using a Patient-Centered Risk-Benefit Structure and Appropriate Manufacturing Practices (AMPs) for Successfully Developing and Manufacturing Effective Cell Therapy Products","authors":"Mark Witcher, Nne Pharmaplan","doi":"10.12665/j152.witcher","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":"15 1","pages":"22-29"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12665/j152.witcher","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
